Urban and rural rates of childhood cancer survival the same, study finds

by Neil Schoenherr,Washington University in St. LouisChildhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new st

Updated on: December 18,2023 23

Urban and rural rates of childhood cancer survival the same, study finds

by Neil Schoenherr,Washington University in St. LouisChildhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new st

Updated on:December 18,2023 23

High fat ketogenic diet envisioned as potential life-saving therapy to combat low platelets in cancer patients

by Delthia Ricks , Medical XpressKetogenic diet promotes megakaryopoiesis and platelet production via β-OHB (A) ELISA detection of serum TPO, c-Mpl, and IL-6 concentrations in control or KDtreated mic

Updated on: December 22,2023 10

High fat ketogenic diet envisioned as potential life-saving therapy to combat low platelets in cancer patients

by Delthia Ricks , Medical XpressKetogenic diet promotes megakaryopoiesis and platelet production via β-OHB (A) ELISA detection of serum TPO, c-Mpl, and IL-6 concentrations in control or KDtreated mic

Updated on:December 22,2023 10

RXR, the cell protein that keeps blood stem cells young and fit

RXR, the cell protein that keeps blood stem cells young and fitby Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Bone marrow histology in a normal mouse and in a mouse lacking

Updated on: October 29,2023 10

RXR, the cell protein that keeps blood stem cells young and fit

RXR, the cell protein that keeps blood stem cells young and fitby Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Bone marrow histology in a normal mouse and in a mouse lacking

Updated on:October 29,2023 10

Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

byInstitute of Cancer ResearchHuman breast cancer cells implanted in an experimental animal with two different tracers (red and blue) to investigate the interaction of tumour cells. Credit:&nbsp

Updated on: December 19,2023 12

Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

byInstitute of Cancer ResearchHuman breast cancer cells implanted in an experimental animal with two different tracers (red and blue) to investigate the interaction of tumour cells. Credit:&nbsp

Updated on:December 19,2023 12

AI-assisted breast-cancer screening may reduce unnecessary testing

byWashington University School of MedicineOn average, radiologists find one case of cancer (bottom images) in every 200 mammograms they evaluate. The top images show no cancer. In a recent study

Updated on: April 27,2024 0

AI-assisted breast-cancer screening may reduce unnecessary testing

byWashington University School of MedicineOn average, radiologists find one case of cancer (bottom images) in every 200 mammograms they evaluate. The top images show no cancer. In a recent study

Updated on:April 27,2024 0

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on: December 17,2023 10

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on:December 17,2023 10

Sexual side effects of cancer treatment often unaddressed with female patients

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients th

Updated on: December 18,2023 10

Sexual side effects of cancer treatment often unaddressed with female patients

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients th

Updated on:December 18,2023 10

Adjuvant Nivolumab Receives CHMP Recommendation for Completely Resected Stage IIB/C Melanoma

July 21, 2023Chris RyanThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of nivolumab monotherapy for the adjuvant treatment of patients at least

Updated on: October 15,2023 191

Adjuvant Nivolumab Receives CHMP Recommendation for Completely Resected Stage IIB/C Melanoma

July 21, 2023Chris RyanThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of nivolumab monotherapy for the adjuvant treatment of patients at least

Updated on:October 15,2023 191

Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers

by Will Cushman,University of Wisconsin-MadisonThis image shows the effect of pro-inflammatory cytokines on the growth of a mouse intestinal organoid. Intestinal stem cells (red) are indicative

Updated on: March 20,2024 13

Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers

by Will Cushman,University of Wisconsin-MadisonThis image shows the effect of pro-inflammatory cytokines on the growth of a mouse intestinal organoid. Intestinal stem cells (red) are indicative

Updated on:March 20,2024 13

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on: December 17,2023 10

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on:December 17,2023 10

Diversity is everyone's responsibility: Researchers outline a path to representation in cancer clinical trials

byAmerican Society of HematologyCredit: CC0 Public DomainA new study published today inBlood Advancesoutlines practical strategies for promoting diversity, equity, inclusion, and acc

Updated on: December 21,2023 10

Diversity is everyone's responsibility: Researchers outline a path to representation in cancer clinical trials

byAmerican Society of HematologyCredit: CC0 Public DomainA new study published today inBlood Advancesoutlines practical strategies for promoting diversity, equity, inclusion, and acc

Updated on:December 21,2023 10

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on: October 15,2023 163

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on:October 15,2023 163